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Conference Proceedings: Aurora Scientific Day 2020
Abstracts published in this supplement were among those presented at the 46th annual Aurora
Scientific Day research symposium, held virtually on May 20, 2020. The symposium provides a
forum for describing research studies conducted by faculty, fellows, residents, and allied health
professionals affiliated with Wisconsin-based Aurora Health Care, a part of the Advocate Aurora
Health health system, which publishes the Journal of Patient-Centered Research and Reviews.

ORAL PRESENTATIONS

Machine Learning Models for Distinguishing Hypertrophic
Cardiomyopathy From Amyloidosis Using Body Surface
Electrocardiograms
Christopher R. Beal, M. Fuad Jan, Arshad Jahangir, A. Jamil
Tajik
Advocate Aurora Research Institute; Aurora Cardiovascular
and Thoracic Services, Aurora St. Luke’s Medical Center
Background: The echocardiogram is the current gold standard for
diagnosing hypertrophic cardiomyopathy (HCM) and amyloidosis.
The equipment and medical expertise required to perform this
procedure and interpret results can be costly and relatively scarce
in some health care systems. The 12-lead electrocardiogram (ECG)
is a widely available, lower-cost tool to establish baseline cardiac
function. If demonstrated to be an accurate method for diagnosing
HCM and amyloidosis, there is potential to expand the diagnostic
capabilities of the ECG for these diseases.
Purpose: To demonstrate the viability of using machine learning
models to diagnose patients with HCM and/or amyloidosis from 12lead ECG data by assigning them to one of two disease groups.
Methods: We analyzed ECG parameters that were extracted from
raw ECG data by the MUSE database. We selected 19 patients
who had undergone previous echocardiograms: 10 patients with
HCM contributed 116 ECG scans, and 9 patients with amyloidosis
contributed 181 ECG scans. A total of 78 ECG parameters were
analyzed from each 12-lead ECG trace, resulting in nearly 300,000
data elements analyzed in this study. The dataset was split into two
parts: 75% of the data was used to train the models, and the remaining
25% was used to validate results. Several different machine learning
models, including neural networks, support vector machines, and
random forests, were evaluated. Model performance was measured
in terms of accuracy, sensitivity, and specificity.
Results: The results from our analysis demonstrate that machine
learning models can distinguish HCM from amyloidosis using 12lead ECG data. Random forests appeared to be the most appropriate
model (accuracy up to 99.80%), while the neural network model
was the least accurate (96.43%). All models had sensitivity and
specificity values greater than 0.96.
Conclusion: Hypertrophic cardiomyopathy can be distinguished
from amyloidosis by machine learning models using 12-lead
electrocardiographic data. Machine learning has the potential to
automate and reduce the cost of diagnosing these cardiac diseases
in more health care systems. Future work will use this approach to
determine if HCM can be distinguished from structurally normal
hearts and/or other cardiac diseases.
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Evaluating Soluble AXL as a Potential Serum Biomarker
for Glioblastoma
Daniel Raymond, Melanie B. Fukui, Robert J. Winn, Amber
LaCrosse, Natalie Polinske, Brittany Last, Beau Adams, Sam
D. Zwernik, Richard A. Rovin, Parvez Akhtar
Advocate Aurora Research Institute; Aurora Neuroscience
Innovation Institute, Aurora St. Luke’s Medical Center; Upper
Michigan Brain Tumor Center, Northern Michigan University;
Biorepository and Specimen Resource Center, Aurora St.
Luke’s Medical Center
Background: We previously found that the cell surface receptor
AXL is overexpressed in glioblastoma (GBM). AXL expression
contributes to both a malignant and metastatic phenotype. While
AXL is abundant in GBM, its expression in normal tissue is low
or undetectable. The extracellular portion of AXL is enzymatically
cleaved, releasing soluble AXL (sAXL). sAXL is detectable in
serum and tumor-related fluid collections and has been described in
melanoma and hepatocellular carcinoma. The relationship between
sAXL and GBM is unclear.
Purpose: To determine if sAXL can be detected in serum from GBM
patients and if there is a correlation with extent of disease.
Methods: We used 84 serum samples from 25 patients with GBM
and 42 samples from 42 healthy volunteers, which were diluted
1:200 in low-cross buffer and phosphate-buffered saline. Aliquots
were stored at -80°C. Samples in low-cross buffer were tested
using a commercially available AXL ELISA kit, and the samples
in phosphate-buffered saline were tested for total protein using a
commercially available bicinchoninic acid assay. Tumor tissue from
15 of the enrolled patients was evaluated for AXL expression using
western blotting. Interpretation of tumor volume was performed using
T1 magnetic resonance imaging scans by a trained neuroradiologist.
Student’s t-test and linear regression were performed to determine
significance of variation.
Results: The mean serum sAXL concentration was 35.77 ± 1.25
ng/mL in the GBM samples compared to 29.99 ± 1.80 ng/mL in
the healthy controls (t(df)=2.652(124); P=0.009). Controlling for
total protein further distinguished the two groups significantly. The
difference between pre- and postoperative sAXL concentrations was
not statistically significant. There was a slightly negative correlation
between sAXL concentrations and corresponding preoperative tumor
volumes. Comparing sAXL concentrations to the AXL expression in
the tumor lysates yielded a stronger negative correlation.
Conclusion: While serum sAXL concentration is significantly
higher in patients with glioblastoma compared to controls, in this
small sample, there was not a significant correlation between sAXL
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levels and volume of GBM. Evaluating sheddase enzyme expression
in the GBM lysates is needed to confirm the lack of correlation
between sAXL in the serum to AXL found in GBM tumor tissue.
Buprenorphine Therapy for Opioid Use Disorder in a
Rural Family Medicine Residency Clinic: Outcomes
Shivani Bhatnagar, Eftu Boru, Munish Kaushik, Jace Varkey,
Marianne Klumph, Jeffrey Tiemstra
Family Medicine, Aurora Lakeland Medical Center; Aurora
UW Medical Group; Center for Urban Population Health
Background: Opioid use disorder (OUD) is a national epidemic.
Office-based medication-assisted treatment (MAT) with
buprenorphine, a partial opioid agonist, is effective and can be
offered by primary care physicians to increase patient access.
Purpose: To assess effectiveness of MAT for OUD in a rural
family medicine clinic and identify factors associated with patient
discontinuation/drop-out of treatment.
Methods: The study was a retrospective chart review of all 123 MAT
patients entering treatment for OUD at Aurora Lakeland Family
Medicine Clinic from January 1, 2018, to July 1, 2019. Data was
collected for the first 6 months or until discontinuation. Variables
studied included basic demographics, opioid first used, history of
heroin use, continued use of illicit/nonprescribed drugs, maintenance
MAT dose, and involvement in behavioral health treatment (BHT).
Data was analyzed using regression analysis and Fisher’s 2-tailed
exact test.
Results: Mean age was 38.7 years; 52% were female, 48% male.
Mean time in MAT was 21 weeks. In all, 63% of patients were
in MAT at 6 months; 58% had remained opioid-free; 65% had
started with prescription opioids; 63% had ever used heroin; and
43% had ever used intravenous heroin. Factors associated with
MAT discontinuation included cocaine in urine drug screen (UDS)
(P=0.049), nonprescribed opioids in UDS (P<0.001), and lack of BHT
(dropout rate: 15% for BHT vs 52% for no BHT; P<0.001). Factors
not associated with MAT discontinuation included age (P=0.407),
gender (P=0.454), history of heroin use (P=0.244) or intravenous
heroin use (P=0.575), alcohol in UDS (P=0.515), nonprescribed
stimulants in UDS (P=0.445), nonprescribed benzodiazepines in
UDS (P=0.201), and maintenance buprenorphine dose (P=0.890).
Conclusion: Over half of patients remained in medicationassisted treatment and opioid-free. Cocaine and illicit opioid use
were associated with decreased retention in MAT, while alcohol,
nonprescribed stimulant, and nonprescribed benzodiazepine use
were not. Participation in behavioral health treatment was associated
with significantly higher retention in MAT, although 48% of patients
not receiving behavioral health treatment also remained in MAT.
National Trends in Delirium Rates of Hospitalized Older
Adults With Heart Failure in the United States (1998–2014)
Ariba Khan, Maharaj Singh, Nasir Sulemanjee, Arshad Jahangir,
Marianne Klumph, Alexander Schwank, Michael L. Malone
Geriatrics, Aurora Sinai Medical Center; Aurora UW Medical
Group; Advocate Aurora Research Institute; Marquette
University School of Dentistry; Aurora Cardiovascular and
Thoracic Services, Aurora St. Luke’s Medical Center; Center
for Urban Population Health
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Background: Delirium is common (17%–38%) in hospitalized
older adults with heart failure (HF). Improved care in the field of
cardiology, along with a decline in HF hospitalizations, may result
in a reduction of delirium associated with HF. However, delirium
is often underrecognized, so the recent national efforts to improve
delirium recognition may result in an increase in delirium diagnosis.
Purpose: To compare the trends in delirium rates over a period of
16 years in patients admitted with a primary diagnosis of HF and to
determine their associated factors.
Methods: The Healthcare Cost and Utilization Project’s National
Inpatient Sample (NIS) database was used to identify older adults
(≥65 years of age) with a diagnosis of HF and delirium from 1998
to 2014. The NIS is a representative sample of 20% of national
hospitalizations. ICD-9 diagnostic codes were used to identify
delirium and primary diagnosis of HF. The trend in the rates of
HF were then compared to patients with and without delirium.
Regression models and chi-squared tests between groups were used
to determine statistical differences.
Results: Out of 1,820,818 patients with a diagnosis of HF, 61%
were White, 56% female, and 4% hospital mortality. Mean age
was 79 years. Delirium diagnosis was identified in 28,937 (1.6%)
patients. There was a reduction in the proportion of HF admissions
that suggested a decline in HF over the study time period (1998
vs 2014; P<0.001). In addition, although not as drastic, there was
a drop in HF admission with a delirium diagnosis (1998 vs 2014;
P<0.001). Patients with delirium, when compared to those without
delirium, had a longer length of stay (7 days vs 5 days; P<0.001),
had higher mortality (13% vs 5%; P<0.001), and were more likely to
be discharged to a nursing home (34% vs 20%; P<0.001). Delirium
diagnosis was more common in Whites (64% vs 36%; P<0.001) and
less likely in females (47% vs 53%; P<0.001). Variables associated
with delirium in logistic regression analysis included male sex, white
race, age, length of stay, dementia diagnosis, admission to a teaching
hospital, elective admission, and Charlson/Deyo comorbidity score
(area under the curve: 0.64).
Conclusion: Overall, primary heart failure alone illustrated a
substantial decrease over the 16-year time period. However, the rate
of delirium in older patients with primary HF was not only much
lower than expected but remained stable in the same time period.
Most importantly, those with delirium had higher inpatient mortality
and length of stay as compared to those who did not have delirium.

POSTER PRESENTATIONS

Incidence of Vitamin D Deficiency in the Internal Medicine
Clinic at Aurora Sinai Medical Center
Daniel Mundt, Wajih Askar, Kayla Heslin, Marianne Klumph,
Kern A. Reid
Internal Medicine, Aurora Sinai Medical Center; Advocate
Aurora Research Institute; Aurora UW Medical Group; Center
for Urban Population
Background: According to the Centers for Disease Control and
Prevention, 10% of the U.S. population has severe vitamin D
deficiency (VDD), with African Americans having the highest
prevalence of low vitamin D concentration. Studies have shown that
VDD is significantly higher among urban midwestern populations.
The detrimental effects of VDD on the bone are well known;
however, recent studies suggest that VDD also might be involved in
the immune, cardiovascular, and neurological system. Nevertheless,
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there is still debate surrounding who, how, and how often individuals
should be screened for VDD.
Purpose: To assess the prevalence of VDD in one internal medicine
clinic and identify risk factors.
Methods: Data were retrospectively collected on unique adult
patients (≥18 years old) who attended the clinic at any point from
January 2018 to December 2018. Vitamin D levels of ≥30 ng/ml
were considered normal, while levels of <30 ng/ml were considered
deficient. Patients who had more than one vitamin D test were
tracked for further analyses. Basic descriptive statistics were used
to describe the population. Chi-squared tests and t-tests were used as
appropriate to compare groups.
Results: Of the patient cohort (n=3,976), only 17.56% had vitamin
D levels tested and 12% had a prior diagnosis of VDD. Of those
tested, 68% were females, 72% were African Americans, and the
average age was 59 years. Unlike race (P=0.80), women, patients
with a previous diagnosis of bone fracture, and those with a current
diagnosis of alcohol use disorder, celiac disease, or chronic kidney
disease were significantly more likely to have vitamin D levels tested
(P<0.01). As expected, individuals were more likely to be tested in
winter than in any other season (42%), and the majority of patients
tested had VDD (71%), including individuals with chronic kidney
disease (P=0.002). However, there were no differences in VVD
based on race (P=0.464). In addition, if a patient was re-tested, they
were more likely to show improvement of vitamin D levels (42%),
although 28% stayed the same.
Conclusion: Although African Americans are generally known to
have lower levels of vitamin D when compared to other races, we
found they were not more likely to be tested nor have more vitamin
D deficiency. Improvement of vitamin D levels for those re-tested
indicates that interventions are being utilized. Parallel to results
previously reported, patients with chronic kidney disease are more
likely to have VDD and could benefit from annual testing for vitamin
D levels. Awareness of these differences could help to lower rates of
VDD in this at-risk population.

sessions covering GOC conversations during 2017–2018. We
reviewed 200 history and physical notes (H&Ps) for 5 full-time
hospitalists before and after training. H&Ps were reviewed only
for patients who were ≥65 years of age and admitted directly to the
intensive care unit. For each hospitalist, only the 20 most recent
charts before and after the intervention were included. Documented
GOC conversations were tabulated, including the use of the GOC
dotphrase. Quality assessment was done by searching for goalconcordant keywords and their synonyms within these conversations.
Basic descriptive statistics were used to describe the population. Chisquared tests and t-tests were used as appropriate to compare groups.
Results: Patient demographics of H&Ps reviewed were as follows:
95% White, 59% female, and mean age 79 years. Older patients
(mean: 84 years) were more likely to have a GOC conversation
(P<0.001). Although there was an increase in usage of the GOC
dotphrase after training sessions (73% compared to 31%; P=<0.01),
only 23% of patients had a GOC conversation. The overall quality
of the GOC conversations both before and after the intervention
remained essentially unchanged (17% vs 18%).
Conclusion: Half-day training sessions in conducting goals of
care conversations were associated with an increased usage of the
GOC dotphrase. Our next steps will be to broaden the scope of this
study by not only retraining hospitalists but also including providers
from other facilities in our analysis, thus increasing the number of
analyzed patient history and physical notes.

Impact of Goals of Care Conversation Training

Background: Acupuncture has been associated with improving
various types of acute pain. Our previous study found that
acupuncture administered in the emergency department (ED) setting
decreases acute pain regardless of analgesics received during visit.
Purpose: To determine if 2 years after program onset, acupuncture
continues to improve pain scores regardless of analgesics used
during ED visits.
Methods: We retrospectively reviewed patients from 2019 who
accessed our ED acupuncture program. Similar to our previously
published work in 2017, acupuncture services were offered to adult
patients (≥18 years old) based on their emergency severity index
(ESI; highest severity [1] – lowest severity [5]), reason for visit,
and physician recommendation. Only patients’ first visit in 2019
was included in analyses. Basic summary statistics were used to
describe patient characteristics. Paired t-tests were used to determine
differences in pre- and postacupuncture pain, stress, anxiety, and
nausea scores (ie, no pain [0] – worst pain [10]). Logistic regression
models were used to determine associations between improvements
in pain and patient or visit characteristics.
Results: Acupuncture services were provided to 199 patients
(mean age: 47.5 years; body mass index: 32.0 kg/m2), who were
predominately female (78.4%) and non-Hispanic White (70.4%)
and who had an ESI score of 3 (63.3%) or 4 (31.2%). As in 2017,
mean pre- and postacupuncture scores for pain (6.7 vs 3.4), stress
(6.3 vs 1.5), anxiety (4.9 vs 1.2), and nausea (1.5 vs 0.4) significantly
decreased (P<0.001 for all). Most patients had a final acute pain-

Temu Brown, Marianne Klumph, Kayla Heslin, Elizabeth A.
Duthie, Tim Jessick
Hospice and Palliative Medicine, Aurora St. Luke’s Medical
Center; Aurora UW Medical Group; Center for Urban
Population Health; Advocate Aurora Research Institute;
University of Wisconsin-Milwaukee; Palliative Care, Aurora
West Allis Medical Center
Background: Palliative interventions by nonpalliative health
care providers such as hospitalists have proved to be beneficial to
patients. A primary task of these providers is to hold goals of care
(GOC) conversations with patients early during their hospital stay.
This can help reserve the expertise of palliative care specialists for
more complex patients. While a previous local evaluation focused on
providers’ overall comfort in initiating GOC conversation before and
after an intervention, no study has explored whether the intervention
resulted in providers having more GOC conversations.
Purpose: To explore whether GOC training sessions increased
hospitalists’ utilization of the GOC dotphrase generated by the
Epic electronic health record; also, to evaluate if there was an
improvement in the overall quality of GOC conversations held with
patients upon admission.
Methods: Aurora Health Care hospitalists participated in training
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Offering Acupuncture to Patients in the Emergency
Department Continues to Decrease Acute Pain
John R. Burns, Jessica J. F. Kram, Jeanne M. Stark Casadont,
Vashir Xiong, Nancy Conway, Dennis J. Baumgardner
Integrative Medicine, Aurora Sinai Medical Center; Aurora
UW Medical Group; Center for Urban Population Health;
Department of Family Medicine, Aurora UW Medical Group

www.aah.org/jpcrr

357

related diagnosis for neck/back pain (41.9%), abdominal pain
(18.7%), or head/headache (14.7%). Improved pain scores were not
associated with any patient characteristics. As in 2017, receiving
opioids only during the ED visit was not associated with improved
pain scores (P=0.21), nor was receiving nonsteroidals (P=0.07) or
tramadol (P=0.42). However, receiving any pain medication in the
ED was associated with improved pain scores (P=0.028). Improved
pain scores was not predictive for receiving any pain medications,
including opioids, at discharge (P>0.05 for all).
Conclusion: Similar to 2017 findings, emergency department
acupuncture remains associated with significantly decreased pain,
stress, anxiety, and nausea. Our findings continue to support ED
acupuncture for acute pain in the ED and further support the need
for a larger randomized controlled trial.
Assessment of Decentralized, Inpatient Pharmacist Blood
Culture Audit and Provider Feedback
Brittany Brown, Thomas J. Dilworth
Aurora Pharmacy, Advocate Aurora Health
Background: Hospitalized patients with blood stream infections
(BSI) are at increased morbidity and mortality risk despite advances
in therapy and overall care. Audit and provider feedback for positive
blood cultures by pharmacists has been shown to improve care and
outcomes for patients with BSI. However, previous studies employed
pharmacy specialists with infectious diseases (ID) training in a
centralized audit and feedback model. It is unknown if decentralized
inpatient pharmacists, with support from ID pharmacists as needed,
could impact patient care similarly.
Purpose: To evaluate antibiotic treatment and outcomes for patients
with BSI for whom blood culture audit and provider feedback was
performed by decentralized inpatient pharmacists.
Methods: This was a retrospective review of 100 adult patients
with BSI in Aurora Health Care with a positive blood culture from
April 1, 2019, to June 30, 2019. Data collected included patient
demographics, blood culture draw time, culture results (gram stain,
pathogen, antibiotic susceptibilities), time to empiric antimicrobial
therapy start, and time to antibiotic optimization. The primary
outcome assessed was time from blood culture draw to effective
empiric antimicrobial therapy. The secondary outcome assessed
was time from blood culture draw to optimal antimicrobial therapy.
Outcomes collected were compared to previously published studies.
Results: 100 patients with positive blood cultures were included.
Urine was the predominant BSI source (47%), followed by skin/
soft tissue (14%). The most common pathogens were gramnegative bacilli (61%). A total of 8 multidrug resistant organisms
were identified. The median time to effective antibiotic therapy
from blood culture draw was 2 hours (interquartile range [IQR]:
1–4.75). The median time to optimal definitive antibiotic therapy
was 36 hours (IQR: 2.13–64). These results are similar to previously
published studies of ID pharmacy specialists in a centralized audit
and feedback model.
Conclusion: Audit of blood stream infections and provider feedback
by decentralized inpatient pharmacists, along with as-needed support
from infectious disease pharmacists, may represent an alternative to
the centralized ID pharmacist model. Application of these findings
to practice will allow for more efficient use of pharmacist time and
expand decentralized inpatient pharmacy practice.
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Fruit and Vegetable Vouchers
Redemption or Consumption

Do

Not

Increase

Andrew McAsey, Priti Rana, Yelena Goschin, Lisa Sullivan
Vedder, Jessica J. F. Kram, Marianne Klumph
University of Wisconsin School of Medicine and Public Health;
Family Medicine, Aurora St. Luke’s Medical Center; Family
Medicine, Aurora Sinai Medical Center; Aurora UW Medical
Group; Center for Urban Population Health
Background: It is well known that a diet rich in fresh fruits and
vegetables improves health outcomes. In central Milwaukee,
specifically the 53233 zip code area, there is a limited supply of
vendors that sell fresh produce to its residents.
Purpose: To increase produce consumption among patients through
a fruit and vegetable prescription (FnVRx) program.
Methods: In 2019, patients at 1 family medicine residency clinic
in the 53233 zip code were recruited and assigned to one of two
groups. The study group was given a packet of materials including
2 $20 prescription vouchers for fresh produce redeemable at the
nearby (1.7 miles from clinic) Fondy Farmers Market, along with a
verbal explanation of packet contents, while the control group was
given the same packet but without verbal overview. Groups were
assigned based on availability of study team member to discuss
packet contents. Participants completed a baseline assessment at
their initial visit; follow-up phone surveys were completed at 4 and 8
weeks post-office visit. Basic descriptive statistics were performed,
and Fisher’s exact tests were used for 2×2 tables.
Results: Of the total participants (N=107), 71% met food insecurity
criteria, 46% had an income of <$15,000, and 89% shared food
with ≥2 family members. Participants were predominantly female
(86%), African American (72%), and in the control group (77%).
Overall, 71% never redeemed a FnVRx. Of those surveyed at 4
weeks postrecruitment, 31% of individuals and 19% of households
recalled consuming more produce, as opposed to 19% of
individuals and 16% of households who had recalled more produce
consumption at 8 weeks. No statistical difference was associated
with redemption of FnVRx in regard to gender, income level, prior
use of farmers’ markets, groups, presence of food insecurity, or
size of household (P>0.05 for all). However, increasing age was
associated with FnVRx redemption (P=0.016). Overall, the most
commonly cited reasons for not redeeming FnVRx were “too
busy” or “forgot.”
Conclusion: The solution to increasing fresh produce consumption
is multifactorial. The answer is not as simple as providing individuals
with monetary-based prescriptions for farmers’ markets. Many
barriers likely prevent increased produce consumption (eg, time,
motivation, transportation, cultural preferences, distance to farmers’
markets, and education). Despite low redemption rates, this project
identified a need for food resources for our patients and further
development of interventions to meet those needs.
Zika Virus Targets Stem Cell Markers and Modulates
Antiviral Responses in Glioblastoma Cancer Stem Cells
Beau Adams, Sam D. Zwernik, Daniel Raymond, Richard A.
Rovin, Parvez Akhtar
Advocate Aurora Research Institute; Aurora Neuroscience
Innovation Institute, Aurora St. Luke’s Medical Center
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Background: Glioblastoma is the most common and lethal form of
brain cancer. Standard treatment involves surgery, chemotherapy,
and radiation. Tumor recurrence is caused by a population of
glioblastoma cancer stem cells (GSCs) that resist and survive
treatment. There are currently no pharmacological agents available
for specific targeting of GSCs. Zika virus (ZIKV) is a flavivirus
that targets normal neural stem cells in the developing brain and
causes microcephaly. ZIKV also selectively targets GSCs in a
similar manner. We examined the effect of ZIKV on specific stem
cell markers as well as antiviral responses in patient-derived GSCs.
Purpose: To understand the oncolytic mechanism of ZIKV toward
GSCs.
Methods: Glioblastoma patient-derived cell lines were acquired
from within our institution and used for the entirety of this study.
Patient-derived cell lines were grown in spheres using supplemented
neurocult media. ZIKV strain MR766 was propagated in Vero cells,
and viral stock was titrated by plaque assays. Glioblastoma patient
cell lines were infected with ZIKV at a multiplicity of infection of 1.
The percentage of infection was quantified by flow cytometry using
a pan-flavivirus antibody. Western blotting was used to characterize
protein expression, while qRT-PCR was used to quantify gene
expression pre- and post-ZIKV infection in patient-derived cell lines.
Results: We tested multiple stem cell markers and found that Sox2
and Nestin expression is highly upregulated in our glioblastoma
patient-derived cell lines (7714, 7730, 7753), while Nanog, Oct-4,
and Musashi-1 were at basal levels. We further found that both Sox2
and Nestin were significantly decreased post-ZIKV infection. Next,
we found that ZIKV induces antiviral responses postinfection through
an increase of interferon-induced genes IRF1, IFIT1, ISG15, and
IL6. Lastly, we found increased expression of FGF2 and Caspase-3
post-ZIKV infection, which are involved in cell differentiation and
cell death, respectively.
Conclusion: Our results suggest that Zika virus infection causes loss
of glioblastoma stem cell self-renewal through decreased Sox2 and
Nestin expression. Furthermore, ZIKV leads to antiviral responses
in GSCs through an increase of multiple interferon-induced genes.
Finally, genes involved in cell differentiation and cell death are
upregulated in GSCs post-ZIKV infection. Thus, there are multiple
mechanisms to explain GSC death following ZIKV infection.
p53 Level and MGMT Promoter Methylation Are Playing
a Role in Zika Virus Replication in Glioblastoma
Sam D. Zwernik, Beau Adams, Jun Yin, Santhi D. Konduri,
Richard A. Rovin, Parvez Akhtar
Advocate Aurora Research Institute; Aurora Neuroscience
Innovation Institute, Aurora St. Luke’s Medical Center
Background: Glioblastoma (GBM) is a malignant primary brain
cancer. The poor median survival rate for patients with GBM of
15 months has not budged for the past 15 years, when the current
standard treatment was first approved. There is no standard-of-care
chemotherapy for recurrent GBM. Needless to say, novel treatments
and treatment strategies for GBM are needed. One such novel treatment
strategy is an oncolytic virus. The Zika virus’ (ZIKV) affinity for fetal
neural stem cells has made it a compelling candidate as an oncolytic
therapy for GBM. Previous studies have shown that ZIKV does infect
and replicate in most but not all GBM cancer cells. Understanding the
genetic milieu that is permissive for ZIKV infection is critical to the
creation of a safe and effective viral oncolytic treatment. This report
presents initial data for a ZIKV replication gene signature.
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Purpose: We hypothesized that p53 level and MGMT promoter
methylation are playing a role in ZIKV replication in GBM cancer
cells.
Methods: ZIKV strain MR766 was propagated in Vero cells.
Viral stock was titrated by plaque assays. Western blot was used
to characterize MGMT, AXL, p53, and Sox2 expression in 8
commercial GBM cell lines (LN229, U87, A172, U251, LN18,
T98G, U137, and U118). The cell lines were stratified by MGMT
promoter methylation status and were exposed to ZIKV at a
multiplicity of infection of 1. The percentage of infected cells was
quantified by flow cytometry using the pan-flavivirus anti-E protein
Ab 4G2. We also compared RNA-seq data of ZIKV replicating and
nonreplicating GBM cell lines to find differentially expressed genes.
Results: In this study, we found that AXL was overexpressed in all
8 commercial GBM cell lines. With flow cytometry, we found that
productive ZIKV replication only occurs in the MGMT-methylated
(LN229, A172, U87, and U251) cell lines and not in MGMTunmethylated (T98G, LN18, U118, and U138) cell lines. qRT-PCR
data showed that ZIKV enters all 8 cell lines but can only replicate
in MGMT-methylated cell lines. Additionally, p53 expression
trended lower in MGMT-methylated cell lines. RNA sequencing
data comparing ZIKV replicating and nonreplicating GBM lines has
identified multiple differentially genes.
Conclusion: Based on these results, there is a clear difference in the
ability of the Zika virus to replicate in glioblastoma cell lines based
on MGMT and p53 expression. Additional work is underway to
understand the mechanism(s) underlying these findings and to define
a ZIKV replication gene signature.
Data in the Electronic Health Record Can Be Used at
the Bedside to Identify Older Hospitalized Patients With
Delirium
Ariba Khan, Kayla Heslin, Michelle Simpson, Michael L.
Malone
Geriatrics, Aurora Sinai Medical Center; Aurora UW Medical
Group; Advocate Aurora Research Institute; Center for Urban
Population Health; Ed Howe Center for Research, Aurora
Sinai Medical Center
Background: Delirium is common among hospitalized older
adults and associated with adverse outcomes. Delirium remains
underrecognized, and efforts are focused on early recognition
and prediction. While several delirium predictive rules have been
developed, only a handful have focused on electronic health record
(EHR) data. The coupling of prediction rules with features of the
EHR are in their infancy but hold promise in their ability to aid in
identification of delirium.
Purpose: To determine variables within our health system’s EHR
that can be used to identify older hospitalized patients with delirium.
Methods: This is a prospective study among hospitalized patients
(≥65 years of age) from February 2016 to November 2017. Patients
were excluded if they: 1) were non-English-speaking, comatose,
ventilated, or combative; 2) were intensive care or surgical patients;
or 3) had severe aphasia, severe dementia, or a critical illness.
Researchers screened daily for delirium using the 3-minute
diagnostic confusion assessment method (3D-CAM). Predictive
variables were extracted from the EHR. Basic descriptive statistics
were conducted. Chi-squared and Fisher’s exact tests were used to
compare differences among those diagnosed with or without delirium.
Binary logistic regression was used for multivariable modeling.
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Results: Among 408 participants, mean age at admission was 75
years, 61% were female, and 83% were African American. The
overall rate of delirium was 16.7% (prevalent delirium: 10.5%
[n=43]; incident delirium: 6.1% [n=25]). There was no statistical
difference in 30-day mortality (2.9% vs 2.7%) or 30-day readmission
rates (13.2% vs 14.7%) between those with and without delirium
(P>0.05 for both). Even so, patients with delirium were older, more
likely to have a diagnosis of infection and/or cognitive impairment,
and more likely to have increased severity of illness (P<0.05 for
all). Moreover, patients with delirium had a lower Braden (pressure
ulcer risk) score and higher Morse fall score (P<0.01 for both). In
multivariable analysis, cognitive impairment (odds ratio: 5.49; 95%
CI: 2.77–10.87) and lower Braden scores (odds ratio: 1.29; 95%
CI: 1.18–1.41) remained significant predictors of delirium among
hospitalized patients.
Conclusion: Our study found that cognitive impairment and lower
Braden scores were associated with hospital delirium. Further
research is needed to develop an automated, dynamic (daily)
prediction model inclusive of these variables.
Usefulness of Procalcitonin in Aiding Physician
Assessment and Treatment of Potential Serious
Bacterial Infections
Jennifer K. Homa, Taylor A. Romdenne, Alex D. Christl,
Ashley R. Heesacker, Darren M. Heesacker
Advocate Aurora Research Institute; Emergency Department,
Aurora BayCare Medical Center; Emergency Department,
BayCare Clinic; Emergency Medicine, BayCare Clinic
Background: Procalcitonin (PCT) is used as a biomarker for the
diagnosis of serious bacterial infections (SBI). To date, studies
have not compared PCT to clinical judgment and it remains unclear
whether PCT adds to the physician’s clinical judgment when
diagnosing SBI.
Purpose: To evaluate the diagnostic usefulness of PCT in comparison
to blood culture results and the physician’s clinical judgment in
patients presenting to the emergency department with signs of SBI.
Methods: A prospective cohort study was conducted with 400
patients suspected of having an SBI who presented to the emergency
department at 2 community hospitals in Wisconsin from 2016 to
2018. PCT was performed on all patients in addition to the standard
of care (SOC) for suspected SBI. PCT results were not available
to the physicians throughout the duration of the study. Physicians
completed a brief survey that asked if they thought the patient was
septic upon ordering SOC labs and again after they reviewed the
SOC lab results. Data were collected to determine if patients were
diagnosed with an SBI during their stay. Multivariate logistic
regression was used to examine factors associated with an SBI
diagnosis.
Results: Among the patients, 186 (46.5%) were diagnosed with an
SBI during their hospital stay. High serum levels of PCT (≥0.25 ng/
mL) were an independently significant predictor for an SBI diagnosis
in patients with signs of infection (odds ratio [OR]: 1.96, 95% CI:
1.13–3.39; P=0.016). In addition, patients suspected of having an
SBI are 2.62 times more likely to be diagnosed with an SBI when
the blood culture result is positive (OR: 2.62, 95% CI: 1.19–5.77;
P=0.017) and 7.13 times more likely to be diagnosed with an SBI
when the physician believes the patient is septic after reviewing the
SOC lab results (OR: 7.13, 95% CI: 3.64–13.97; P<0.001). There
was no association between the physician’s clinical judgment before
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reviewing the SOC lab results and SBI diagnosis (OR: 1.74, 95% CI:
0.88–3.45; P=0.111). None of the other factors, including lactic acid,
were found to be significant predictors for an SBI diagnosis.
Conclusion: Procalcitonin, blood culture results, and clinician
judgment after reviewing standard-of-care labs provide important
diagnostic value when diagnosing serious bacterial infections.
Clinician judgment before reviewing SOC lab results was not
associated with an SBI diagnosis; thus, SOC labs do have added value
in aiding physician assessment of potential SBI. This study offers a
unique perspective as, to date, no other studies have compared PCT
results to clinical judgment.
Goals of Care Conversations: A Training Program
Evaluation
Elizabeth A. Duthie, Colleen M. Galambos, Theresa Frederick,
Jacob Verkuilen, Tim Jessick
University of Wisconsin-Milwaukee; Center for Urban
Population Health; Helen Bader School of Social Welfare,
University of Wisconsin-Milwaukee; Continuing Professional
Development, Advocate Aurora Health; Palliative Care
Medicine, Aurora West Allis Medical Center
Background: Patients benefit when their health care providers
engage in conversations about treatment options and goals of care.
However, these conversations frequently do not occur. Researchers
have called for new approaches to increase such conversations. The
Teaching Primary Palliative Care Training program is one such
approach.
Purpose: To determine whether Teaching Primary Palliative Care
Training increases participant comfort engaging in goals of care
conversations with seriously ill and dying patients shortly after the
training and 1 year after the training.
Methods: 78 health care providers participated in Teaching Primary
Palliative Care Training during the fall of 2018. Participants
completed a self-assessment in which they reported on their comfort
level in various circumstances related to the management of seriously
ill and dying patients at baseline before the training, shortly after
completing the training, and again 1 year later. We used the 1-sided
sign test to assess for statistically significant improvement in selfreported comfort.
Results: At the first follow-up, self-assessments reflected significant
improvement in comfort, compared to baseline, in all 5 circumstances
related to the management of seriously ill and dying patients. These
circumstances included: delivering bad news (P=004); discussing
CPR/DNR (P=003); discussing hospice or palliative care referral
(P=001); discussing artificial hydration or nutrition (eg, percutaneous
endoscopic gastrostomy tubes) (P<001); and discussing prognosis
specifics (P<001). At 1-year follow-up, significant improvement
remained in 4 of the 5 circumstances compared to baseline: delivering
bad news (P=0.010); discussing hospice or palliative care referral
(P=0.006); discussing artificial hydration or nutrition (P=0.002); and
discussing prognosis specifics (P=0.009).
Conclusion: In this sample, participation in the Teaching Primary
Palliative Care Training program increased health care provider
comfort in patient communication of various circumstances
related to the management of seriously ill and dying patients.
Improvements continued 1 year after the training. Next steps
include determining whether increased comfort translates into
changes in provider behavior such as conducting goals of care
conversations with patients.
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Medication Refill Protocol at a Residency Clinic
Carl M. Bellinger, Patrick Foss, Fabiana Kotovicz, Dennis J.
Baumgardner, Marianne Klumph, Jessica J. F. Kram
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
UW Medical Group; Center for Urban Population Health
Background: In primary care clinics, prescription refill requests
significantly impact day-to-day clinic workflow and can increase
clinician burnout and patient dissatisfaction. Delays in response
cause gaps in treatment leading to potential patient adverse events
and stress on patient/provider relationships.
Purpose: To decrease the time to complete refill requests (refill
approved or declined) and improve consistency in management of
refills.
Methods: We created an interdisciplinary refill protocol based on
state Medicaid preferred drug list data to allow for centralized,
nursing-driven management of most prescription refills at a family
medicine residency clinic in Milwaukee, Wisconsin. Medication
refill processing time (from the time a refill encounter was open with
a refill request to the time it was closed with refill approval or denial)
was measured in minutes and was compared preprotocol (March 1,
2017, to November 30, 2017), during protocol adoption (December
1, 2017, to August 31, 2018), and postprotocol (September 1, 2018,
to June 28, 2019). Mood median test was used to compare the
average time for a medication refill request to be addressed. Levene’s
test was used to test for equal variance surrounding the median of
each group.
Results: Cohorts included preprotocol (n=24,073), protocol
adoption (n=23,770), and postprotocol (n=25,770). We found a
statistically significant reduction in median time to refill completion,
from 232 minutes in the preprotocol phase to 157 minutes in the
postprotocol phase (P<0.001). Reduction in median time to response
was most apparent in the resident subgroup, with median times of
383 minutes preprotocol and 79 minutes postprotocol (P<0.001).
There also were statistically significant reductions in variability
of response time. Response time standard deviations (SD) had an
overall reduction across groups (preprotocol mean SD: 14.5 days;
during protocol adoption mean SD: 10.8 days; postprotocol mean
SD: 6 days; P<0.0001).
Conclusion: This project reinforces the importance of a standardized
multidisciplinary medication refill protocol to increase consistency
and decrease medication refill time. Results from this project are
being used to further improve and expand the process of medication
refill within both of our academic family medicine clinics.
Substance Use Disorder Treatment Outcomes and
Transitions at a Large Midwestern Health Care System
Mindy R. Waite, Kayla Heslin, Jonathan Cook, Elizabeth
Wanninger, Michelle Simpson, Andrew J. Freeman
Advocate Aurora Research Institute; Aurora Behavioral Health
Services
Background: Substance use disorder (SUD) is diagnosed in 10%
of the U.S. population across a lifetime. Although around 10% of
individuals with SUD go into long-term remission each year, the
disease is considered chronic and is punctuated by many periods of
abstinence, relapse, and eventual long-term remission. Nevertheless,
only 35%–50% of individuals with SUD experience long-term
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remission within 17 years of diagnosis. To account for disease
chronicity and varying levels of need over time, several treatment
programs exist, each tailored to an individual’s current acuity
and needs. These treatments include inpatient, residential, partial
hospitalization program (PHP), intensive outpatient program,
and outpatient treatment. Patients are assessed and referred for a
specific level of treatment, and individual outcomes are superior if
patients enter and complete the recommended program. However,
many patients choose to reduce their lengths of stay, discharge
against medical advice, or enter programs mismatched with their
current acuity.
Purpose: This retrospective study describes patient populations
within the 5 unique SUD programs as well as variables related to
program completion and length of stay.
Methods: Medical records were used to collect data. Eligible
subjects were adults enrolled in SUD treatment at a midwestern
psychiatric hospital between January 1, 2017, and November 20,
2019. Data included demographics, diagnoses, tobacco use, number
and length of stays, referrals, discharge against medical advice, and
program type. Basic descriptive statistics were conducted.
Results: Of the total population (N=4990), the majority of patients
receiving treatment for SUD were male (59.9%), current smokers
(61.8%), and had a mean age of 39.9 years. Further, many patients
had concurrent mental health diagnoses; depression and/or anxiety
disorders were prevalent in 53%–57% of patients. Within the
context of substance use, patients were most likely to have been
diagnosed with alcohol use disorder, opioid use disorder, cocaine
use disorder, and cannabis use disorder. Similarly, patients
were most likely to receive treatment for alcohol use, cannabis
use, opioid use, and cocaine use. Co-occurring diagnoses were
extremely common, and patients in PHP programming had the
greatest number of diagnoses.
Conclusion: Patients receiving treatment for substance use disorder
are highly varied, and population differences exist among programs.
These data suggest opportunities for tailoring programs to meet the
current and long-term needs of patients.
Concordant Genomic Vulnerabilities of Patient-Derived
Cell Line and Matched Xenograft-Derived Cell Line
Through Whole Exome Sequencing in Breast-to-Brain
Metastatic Cancer
Jun Yin, Aspen Duffin, Kate Dennert, Deborah L. Donohoe,
Parvez Akhtar, Richard A. Rovin, Judy A. Tjoe
Advocate Aurora Research Institute; Aurora Neuroscience
Innovation Institute, Aurora St. Luke’s Medical Center; Surgical
Oncology, Aurora Sinai Medical Center
Background: Brain metastasis (mets) is often associated with the
worst prognosis among all disseminated disease, and one of the
two main sources of brain mets is the breast, with reported 1-year
survival rate of 20% once developed. Breast-to-brain mets (BBM)
usually happens in a late stage of breast cancer, and options of
treatment are very limited, which becomes a major limitation of life
expectancy. Therefore, developing a cost-efficient, robust model
that could precisely recapitulate the features of tumor origin would
be beneficial to discovery of novel therapeutic strategies to further
improve outcomes.
Purpose: Patient-derived xenografts (PDXs) often accurately
recapitulate the tumor of origin in terms of genomic landscape,
histopathology, and therapeutic response; however, restrictions
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such as cost, high maintenance, and limited amenability for
large-scale screening for potential therapies remain a challenge.
To overcome these issues, we established a platform to derive
cell lines from both a patient’s BBM tumor and the matched PDX
to further investigate the similarity of their pathogenic genomic
variants.
Methods: DNAs from the first passage of cells derived from patient
tumor along with 2 different passages of cells derived from PDXs
were extracted, followed by whole exome sequencing analysis. Raw
FASTQ files were quality controlled using FASTQC and then aligned
to hg38 using BWA-MEM without trimming. The aligned BAM files
were processed using GATK4, following best practice. Mutations
were called using mutect2 without normal control. Classification of
variants was finally referred to ClinVar.
Results: Cells derived from PDXs (PDXL) has a significantly shorter
doubling time than cells derived from patient tumor (PTL). PDXL
was able to recapitulate the entire spectrum of PTL’s pathogenic
variants. Exome sequencing analyses delineated several pathogenic
variants of some common oncogenes and tumor suppressors, which
potentially contributed to progression of this tumor. PDXL and
PTL have shown consistent response to drugs that target the certain
pathogenic variants.
Conclusion: Our patient tumor-PDX cell line platform represents a
preclinical tool for functional gene validation and proof-of-concept
studies to identify novel druggable vulnerabilities in BBM, which
could be further applied to other types of brain mets.

their own music. Most women (35%) listened to music for 30–
39 minutes during their chemotherapy session. Choice of music
genre varied greatly between women. Ultimately, 70% of women
participated in another activity in addition to listening to music,
with 85% choosing to switch to another activity entirely at some
point during their chemotherapy session. The most common
activities patients engaged in besides music therapy included
talking to family and friends (65%), social media (30%), reading
(25%), and sleeping (25%). Women found music therapy to be
very helpful, relaxing, and a good time-filler.
Conclusion: Although many women listened to music during
their chemotherapy, most also engaged in another activity,
sometimes switching completely to that other activity. Based
on our findings and the difficulties of even surveying patients,
participation in a larger study aimed at evaluating effects of music
therapy on chemotherapy in women with gynecologic cancers
may be quite difficult.

Gynecologic Cancer Patients’ Interests in Music Therapy

Background: Primary care providers in Milwaukee are surrounded
by a diverse community, often hearing stories of overcoming
adversity. Celebrating patients’ and staffs’ successes are part of
what makes medicine so rewarding. The concept of Humans of
Family Medicine stems from the Instagram account Humans of
New York, which highlights the stories of everyday people in New
York City.
Purpose: To highlight and share unique patient and staff stories
in hopes of bringing a humanitarian side to the practice of family
medicine.
Methods: We conducted a quality improvement project at 2 family
medicine clinics within Milwaukee County during 2019. The project
was approved by the local institutional review board. Consent was
obtained from patients and staff who agreed to have their story
told. The stories were written and then vetted by our social media
team, before being published on institutional social media accounts.
Family medicine providers and staff were surveyed before and after
the project to gauge use of social media and thoughts on the project.
Pre/postsurvey responses were compared with Fisher’s exact tests.
P-value less than 0.05 was considered significant.
Results: A total of 25 individuals were asked if they would like to
participate and share their story; 1 declined. In all, 24 stories were
written; 18 have been published (3 on Facebook [FB] alone, 0 on
Instagram [IG] alone, and 15 on both platforms). Of the 24 stories,
12 were current patients, 10 were staff members, and 2 were
resident physicians. Mean FB likes were 485 (range: 75–1155),
and mean IG likes were 96 (range: 45–490). Mean FB comments
were 33 (range: 3–173), and mean IG comments were 5 (range:
0–56). Family medicine providers and staff (n=23 presurvey; n=28
postsurvey) were significantly more likely to follow our institution
on Facebook following project implementation (P=0.005).
Additionally, family medicine providers and staff were significantly
more likely to think it was a good idea to showcase patient and
staff stories on social media following the project (P<0.001). Those
surveyed initially were unsure of whether their patients would

Stephanie N. Veit, Jessica J. F. Kram, Kayla Heslin, Elizabeth
L. Dickson Michelson
Obstetrics and Gynecology, Aurora Sinai Medical Center;
Aurora UW Medical Group; Center for Urban Population
Health; Advocate Aurora Research Institute; Gynecologic
Oncology, Aurora West Allis Medical Center
Background: Music therapy has been used as complementary
therapy in oncology patients undergoing chemotherapy for decades.
Several studies have suggested potential benefits associated with
music therapy use, including alleviation of mood symptoms like
anxiety and other common chemotherapy side effects like nausea
and vomiting. Although case reports have reported music therapy
use among women with gynecologic cancers, no formal studies have
been conducted.
Purpose: To evaluate patients’ thoughts on music therapy as an
adjunct to chemotherapy and to evaluate patients’ use of music
therapy in comparison to other media types.
Methods: We conducted a feasibility study that prospectively
surveyed adult women undergoing chemotherapy for a gynecologic
cancer (endometrial cancer, ovarian cancer, cervical cancer, etc)
within 1 hospital center from June 2018 to July 2019. Women
were asked demographic and preliminary questions prior to being
provided preselected music on an audio listening device. Following
their chemotherapy session, women were asked to complete a survey
remarking on their thoughts about music therapy and use of other
media. Basic descriptive statistics were conducted.
Results: Overall, 20 women completed surveys, of which 50%
were 30–59 years of age, with the remainder greater than 60 years
of age. Women were predominately Caucasian (75%) and mostly
had either ovarian (50%) or endometrial (45%) cancer. Overall,
80% of women chose to listen to the music provided instead of
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Humans of Family Medicine
Dane Olsen, Anna E. Karst, Glenda Sundberg, Sarah A.
Bowlby, Jessica J. F. Kram
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
St. Luke’s Family Practice Center; Aurora UW Medical Group;
Center for Urban Population Health
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like their stories showcased (36% “yes, would like”). Following
the project, 82% thought patients would like being showcased on
social media (P=0.001).
Conclusion: Humans of Family Medicine creates a platform to
share stories about the people we serve and is something our staff
and providers think is a good idea. It is possible that showcasing
these stories may bring a more humanitarian side to the practice of
family medicine.
Hot Spotting Medically Complex, Socially At-Risk
Patients Accomplishes the Quadruple Aim
Keyonna Taylor-Coleman, Glenda Sundberg, Jessica J. F. Kram
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
St. Luke’s Family Practice Center; Aurora UW Medical Group;
Center for Urban Population Health
Background: The goal of the quadruple aim for health care is to
1) improve patients’ experiences, 2) address social determinants of
health, 3) reduce health care costs, and 4) prioritize the well-being
of care team members. Hot spotting, or collaborating with other
health care professionals to create a care plan to address our most
complex patients, may accomplish the quadruple aim.
Purpose: To illustrate that hot spotting addresses the ideology
behind the quadruple aim.
Methods: Across 3 clinic sites in 2019, providers recommended
patients who would benefit from the hot spotting intervention
(preintervention period: June 1, 2018–February 28, 2019;
postintervention period: March 1, 2019–December 1, 2019). Three
times per year, interdisciplinary teams at each site completed care
plans for each patient. Patients received at least 1 home visit and
increased calls from nursing/social work. Social determinants of
health were assessed. Hospitalizations and emergency department
visits were compared. Pre- and postintervention surveys were
conducted by staff and providers involved in hot spotting. Basic
descriptive statistics, and Mann-Whitney U test when appropriate,
were conducted.
Results: In all, 64 patients were hot spotted. Patients were
predominately female (69%), African American (60%), Englishspeaking (89%), and had Medicare/Medicaid insurance (100%).
Patient ages ranged from 2 to 98 years. Patients lived on average
within 3.7 ± 2.8 miles to their respective clinics. Addressing the
first aim, hot spotting improved the patient experience for 78% of
patients who received additional coordination of care as a result
of their involvement that differed from the traditional health care
model. Evaluation of the social determinants of health revealed
concerns with transportation (39%), food insecurity (31%), safe
relationships (34%), financial safety (45%), and safe housing (36%),
allowing providers to better address these needs during home visits
and accomplish the second aim. Moreover, for a third year, although
not statistically significant, emergency department visits decreased
among hot spots (13.1% decrease), implying cost savings. Overall,
prior to and following the hot spotting intervention, a majority of
survey respondents felt that they were able to provide better care to
their patients because of the intervention.
Conclusion: Hot spotting accomplishes the quadruple aim by
1) demonstrating improved patient experience, 2) addressing
underlying social determinants of health, and 3) reducing health
care costs, while 4) showing an overwhelmingly positive care team
response to the intervention.
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Correlation of Occurrence of Legionella pneumophila
and Blastomycosis Cases Within Zip Codes: Eastern
Wisconsin
Dennis J. Baumgardner
Department of Family Medicine, Aurora UW Medical Group;
Center for Urban Population Health
Background: Legionella pneumophila (intracellular bacteria)
pneumonia (LpP) and blastomycosis (from the dimorphic fungi
Blastomyces) are potentially serious environmentally acquired
infections that are both prevalent in Wisconsin. There is good
evidence that blastomycosis is associated with waterways and
preliminary evidence that some LpP may be as well. If the acquisition
of both diseases is similarly associated with a geographic feature,
one might expect similar geographic distributions of case addresses.
Purpose: To perform a preliminary exploratory analysis of the
correlation of the distribution of LpP and blastomycosis cases among
zip codes in eastern Wisconsin.
Methods: We conducted secondary data analyses of 2 ACL
Laboratories registries covering eastern Wisconsin from
overlapping 5-year time periods: positive L. pneumophila urine
antigen tests (LUAT), which fit Centers for Disease Control
and Prevention criteria for diagnosis, from 2013 to 2017, and
laboratory-confirmed blastomycosis cases from 2015 to 2019.
Number of respective cases, by zip code, were compared for zip
codes 530xx–532xx and 534xx containing 5 or more LUAT results.
One zip code outlier was eliminated. Incidence figures for each
disease were calculated from our previously published analysis
data. Pearson correlation was calculated, and linear regression
was performed with LpP case distribution as outcome variable and
blastomycosis distribution as predictor.
Results: Yearly predicted LpP and blastomycosis cases in the eastern
Wisconsin catchment area were 27 and 24, respectively, such that
an approximately 1:1 distribution was assumed. Pearson correlation
of distribution of LpP and blastomycosis cases by zip code was
moderate at 0.541 (P<0.001). Of 136 zip codes from 11 counties
studied, 61 had no LpP or blastomycosis cases, 35 both types of cases,
24 only LpP cases, and 16 only blastomycosis cases. Blastomycosis
case distribution was a significant predictor of LpP cases in a linear
regression model (P<0.001), with equation LpP cases by zip = 0.419
+ 0.636(number of blastomycosis cases); adjusted R2 = 28.7%.
Conclusion: This preliminary, modest correlation of the zip code
distribution of L. pneumophila pneumonia and blastomycosis
is intriguing given known association of LpP with human-built
water sources. It may suggest an undescribed common outdoor
environmental source. Further study of LpP and blastomycosis coassociations with waterways, and other potential common sources
(or common environmental hosts such as Acanthamoeba in which
both can propagate), seems warranted.
Identifying the Value of Graduate Medical Education to a
Health Care System
Deborah Simpson, Thomas J. Hansen, Jacob Bidwell, Mary
Joyce Turner
Family Medicine, Advocate Aurora Health; Academic Affairs,
Advocate Aurora Health; Aurora Graduate Medical Education,
Advocate Aurora Health
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Background: Our newly merged health care system sponsors
more than 650 residents and fellows in our accredited programs.
Sponsoring graduate medical education (GME) programs requires
a significant financial and human investment from multiple parts
of the organization — ranging from executive leadership/board/Csuite/hospital leaders to leaders responsible for human resources,
legal, finance, quality, and safety.
Purpose: To identify what system leaders perceived to be GME’s
value to our health care system.
Methods: Our GME leadership team developed brief questions
seeking to have interviews of <20 minutes: 1) When you need to
advocate for the value of our GME programs, what do you highlight?
and 2) What do you wish others would value about our GME
programs? Three authors were assigned to contact a key system
leader through email, phone call, or face-to-face. Project purpose
was explained (eg, interested in their perceptions in regard to the
value of GME to our organization) and leader asked if they would
be willing to meet with us. A field notes worksheet was created for
interviewers to note key findings. Respondent’s leadership role (eg,
executive team, C-suite, hospital president/chief medical office,
finance/legal) was recorded, along with their responses to each
question. Responses were then coded and categorized using standard
qualitative methodology to identify cross-cutting themes.
Results: Of 31 leaders approached, 29 (94%) agreed to be interviewed,
with field notes analyzed. The top 4 areas our system leaders
highlighted when advocating for GME, with little/no disagreement
by leadership role, were: 1) its value and cost-effectiveness as a
pipeline for physician recruitment; 2) GME’s contribution to a
culture of continuous learning; 3) the prestige/reputation associated
with being an organization that trains future physicians; and 4) the
expectations of the community and the profession to train the next
cohort of physicians. Typical response was that residents create a
“healthy tension in the organization. Organizations are built to just
‘do,’ not to create questions/reflect … it wouldn’t happen without
education programs.” All 4 of these areas matched what leaders
wished others valued about our GME programs, with 1 area added:
the infrastructure needed to support education.
Conclusion: Identifying graduate medical education’s value beyond
a workforce pipeline allows GME leaders to emphasize GME’s
broader assets to the organization. Our next step is to engage
program directors on metrics for these values and share those
findings to further enhance GME’s value to the organization.
Radiation Exposure, Reduction Techniques,
Standardization of Swallow Study Evaluations

and

Mason A. Brown, Shelly Reimer, Leah Presper, Theresa
Acherman, William MacDonald
Diagnostic Radiology, Aurora St. Luke’s Medical Center;
Speech Pathology, Advocate Aurora Health; Radiology,
Advocate Aurora Health
Background: Long-term exposure to ionizing radiation from
fluoroscopic procedures can lead to deterministic and stochastic
effects not only for the patient but for medical personnel as well.
Swallow study evaluations are the most frequent fluoroscopic
procedures performed and often require a speech pathologist,
fluoroscopy technician, and radiology resident to be present in the
room during the study. While C-arm radiography machines calculate
the estimated absorbed radiation dose to the patient, cumulative
radiation exposure badge data and baselines for medical personnel
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are difficult to interpret, track, and maintain.
Purpose: Establishing a fluoroscopic radiation exposure baseline in
radiology residents may help in estimating other medical personnel
exposure and monitoring future reduction techniques.
Methods: For the baseline radiation exposure analysis, fluoroscopic
study data were retrospectively collected. Powerscribe is a radiology
dictation software in which study reports are organized, and we sorted
each resident’s studies into a database. Swallow study absorbed
dose, which is ionizing radiation absorbed per unit mass measured
in grays (Gy), is recorded with respect to the patient’s dosing. This
amount was used to estimate the radiology resident’s radiation
exposure utilizing an intensity calculated based off a distance of 2.5
m. Radiation exposure data were analyzed per individual residents
in the current PGY3 class. Future methods include implementing
reduction techniques and analyzing radiation exposure data in the
current PGY2 class.
Results: Patient radiation exposure data per swallow study
evaluation averaged 1.9 minutes (median: 1.8 minutes, range: 0.3–
4.3), where the average radiation exposure was 7.9 mGy (median:
7.2 mGy, range: 1.5–24.3). Residents performed approximately 5
swallow studies/day, or 100 swallow studies/4-week rotation. By
utilizing an intensity calculation of Intensity = 1/distance2, estimated
resident radiation exposure over 8 weeks (2 × 4-week rotations) was
367.7 minutes (6.1 hours) and 23.9 mGy.
Conclusion: In residents, exposed areas of skin receive an ionizing
radiation dose equivalent to 3 computed tomography scans per
4-week fluoroscopy rotation. Eye lenses have a deterministic
threshold of 2–6 Gy. Residents absorb more than 10% of the lower
end of this threshold during their first year of radiology training.
Speech pathologists and fluoroscopy technicians without protective
equipment could be at similar risk levels.
Improving Timeliness of Early Hospital Discharges: A
Quality Improvement Project
Itamar Gnatt, Alice Shallcross, Leart Neziri, Jessica J. F. Kram,
Javier Leiva, Marianne Klumph, Fabiana Kotovicz
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
UW Medical Group; Center for Urban Population Health;
Performance Advisory, Advocate Aurora Health
Background: Delayed hospital discharges create bottlenecks in
health care systems, increase health care costs, backlog emergency
departments, and leave hospitalized patients susceptible to infections
and emotional distress. Several studies have identified barriers to and
interventions for discharge timeliness in order to decrease the impact
of delayed patient discharges.
Purpose: This quality improvement project aimed to explore and
identify barriers to early discharge for patients within one hospital
teaching service.
Methods: From August 2019 to November 2019, semi-structured
interviews with family medicine faculty, residents, and hospital
nurses were performed and recorded to further explore barriers
and opportunities to early (before noon) discharge within a tertiary
academic hospital in urban Milwaukee, Wisconsin. Transcribed
interviews were further reviewed using qualitative software Dedoose
8.3.17 for thematic inductive analysis. Additionally, an online
survey for residents was distributed and basic descriptive statistics
calculated to summarize survey responses.
Results: Through qualitative analyses, 4 themes were identified.
Overarching themes included: 1) barriers to early discharges (eg,
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suboptimal communication [components cited 87 times during
interviews], safety concerns [cited 4 times], language/transportation
barriers [cited 60 times], specialty clearance [cited 20 times]); 2)
suggestions for improvement (eg, electronic health record tools,
examples of good communication, clear expectations, waiting
lounge, process standardization); 3) discharge planning process (eg,
timely medicine reconciliation and order [cited 17 times], patient
discharge expectations [cited 15 times]); and 4) system implications
of discharge by noon (eg, workflow improvement, communication
improvement).
Conclusion: Our findings highlight the need for standardization
of discharge workflow and potentially modifiable early-discharge
barriers. Results from this study will be used to implement
interventions and educate providers on ways to optimize early
hospital discharges.
Group Visits in Chronic Disease Management
Dane Olsen, Christina Quale, Fabiana Kotovicz, Jessica J. F.
Kram, Marianne Klumph, Karen Pankowski
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
St. Luke’s Family Practice Center; Aurora UW Medical Group,
Center for Urban Population Health
Background: Chronic disease management encompasses most
of a primary care provider’s practice. However, brief office
visits often pose a challenge to provide comprehensive patient
education for their chronic conditions. One modality thought to
improve management of chronic diseases is the group medical
visit model. Even so, despite proven benefits for patients and
medical providers, creating a sustainable chronic disease group
is challenging.
Purpose: To identify the benefits and challenges of developing and
maintaining a group visit model at academic primary care clinics in
urban underserved settings.
Methods: Semi-structured interviews (N=9) with team members
who had previously led or participated in group sessions for
chronic disease management at 2 academic primary care clinics
in Milwaukee, Wisconsin, were performed and recorded from
October 2018 through March 2019. Interviews were reviewed by
2 different investigators who independently coded transcriptions
using inductive methods using qualitative software (Dedoose
v.8.3.17). Codes generated independently were then integrated into
a single codebook by a third investigator.
Results: Three major themes were identified from the interviews:
1) Expected and actual benefits (eg, overall patient and provider
satisfaction [56% of interviewees identified], patient empowerment
[67%], more time with patients [34%]); 2) Expected and actual
challenges (eg, recruitment [78%], retention [100%], scheduling
of providers [45%], language barriers [23%], poor health literacy
[34%]); and 3) Advice for providers conducting future group visits
(eg, establishing a consistent leader to champion the group visit
[23%], develop a well-organized curriculum [56%], understand
reimbursement [23%]).
Conclusion: Group medical visits have several inherent barriers,
especially around recruitment and retention. Even so, interviewees
identified that group medical visits are beneficial to both patients
and providers. Given the identified potential patient benefits, such
as patient empowerment and improved health literacy, findings
from our qualitative study will be used to identify resources to
promote group visit success.
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Blood Lead Screening Rates in Children Aged 12–35
Months Within a Milwaukee Family Medicine Residency
Clinic
Priti Rana, Morgan Lively, Marianne Klumph, Do Dang, Bonnie
Bobot, Alonzo Jalan
Family Medicine, Aurora St. Luke’s Medical Center; Aurora
UW Medical Group; Center for Urban Population Health;
University of Wisconsin School of Medicine and Public Health;
Family Medicine, Aurora Sinai Medical Center
Background: There is no safe level of lead in the body. Elevated
blood lead levels primarily affect the development of the central
nervous system. Blood lead levels are highest between the ages of
18 and 36 months secondary to an increase in mobility and hand-tomouth behavior. Children in the city of Milwaukee are recommended
to be screened for lead levels at 12, 18, and 24 months, followed by
annual screening through the age of 5. Yet, Milwaukee continues to
have a greater proportion of children who test positive for elevated
lead levels compared to the national average.
Purpose: To review the rate of lead screening in children aged
12–35 months at Aurora Sinai Medical Center’s Family Care Center
(FCC) clinic and to identify risk factors.
Methods: Data were retrospectively collected from Aurora Health
Care’s electronic health records and the Wisconsin Lead Registry on
children 12 to 35 months old who attended FCC for well-child exams
from October 1, 2018, to September 30, 2019. The screening results
were sorted into the age groups of 12–17, 18–23, and 24–-35 months,
giving us a snapshot of screening rates. Basic descriptive statistics were
computed, and Fisher’s exact test was used for categorical analysis.
Results: A total of 383 patients were included for analysis. In all,
there was an equal percentage of females and males; 72% were
Black, followed by 10% White, and 10% Hispanic. Appropriate lead
level screening rates of children by age were as follows: 45% for
12–17 months, 26% for 18–23 months, and 35% for 24–35 months.
Overall, 62% of 12–35-month-old children at FCC had at least one
blood lead test. There was no statistically significant difference in
screening based on race as defined by Black vs non-Black (P=0.56).
However, there was a statistically significant difference between
insurance carriers, with Medicaid patients being screened more than
those with other types of insurance (P=0.016).
Conclusion: Lead screening rates at FCC were comparable to
statewide screening. The higher screening rate for Medicaid patients
may likely be due to having additional access to WIC services and
recommended point-of-care lead testing. Implementation of point-ofcare lead testing at FCC may improve overall future screening rates.
Adoption of Macy Catheter by Aurora at Home Hospice
Staff: A Quality Improvement Evaluation Study
Patrick B. Herson, Kavita Sharma, Kristi Barfield, Nora
Clapsaddle
Hospice and Palliative Care Medicine, Aurora St. Luke’s
Medical Center; Hospice Care, Aurora Health at Home
Background: The Macy Catheter (MC) is a tool to aid rectal
delivery of oral medications in microenemas. In 2019, Aurora Health
at Home hospice chose the MC as a preferred route for delivery of
medications when patients no longer tolerate the oral route. Despite
training, adoption of the MC has been slow.
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Purpose: To determine what barriers exist to faster adoption and
utilization of the MC by hospice nursing staff. It is anticipated
that once the barriers are identified they will be addressed through
a campaign of quality improvement projects with subsequent
monitoring of adoption.
Methods: An anonymous survey was given to 28 nurses at 2
meetings. The survey identified nurses that used the MC and their
experiences. Nurses who had not used it were queried to see if
they had no eligible patients or, if they had eligible patients, what
their reasons were for not using it. Demographic data included age,
experience as a registered nurse (RN) and hospice RN, usual shift
worked, and work status. Basic descriptive statistics were used to
describe the population.
Results: Of a total of 28 surveys completed, 7 reflected use of the MC,
with most using it only once and 1 using it 3–5 times. The number of
medication doses given ranged from 1 to 10–20. There was an overall
agreement regarding the ease of the MC insertion and its effectiveness
when compared to the oral route. There were no complications noted.
Ten nurses reported to never have used the MC because of not having
eligible patients, while 12 reported having eligible patients and not
using the MC, though 9 considered it. Common reasons for not using
it include patient/family objections, inexperience using the MC, or
confidence in other methods. One nurse reported not using it due
to a nursing facility policy. Of those who had eligible patients and
who did not consider using it, reasons given included unfamiliarity
and not thinking of it in the “heat of the moment.” There were no
demographic differences among these groups that would account for
their willingness to use or consider the MC.
Conclusion: The study identified leadership opportunities to increase
the use of the Macy Catheter. Experienced nurses can help train and
teach their peers how to “sell” this device to patients, families, and
other clinicians. There is a need to develop educational collateral to
help families understand the utility of the MC. We can work with
facilities to make sure their policies align with the latest nursing
approaches for excellent hospice care.
Medical Students Add Value in Your Clinical Setting
Deborah Simpson, Mark Robinson, Kjersti Knox, Theresa
Frederick, John R. Brill
Family Medicine, Advocate Aurora Health; Clinician Student
Services, Academic Affairs, Advocate Aurora Health; Training
in Urban Medicine and Public Health (TRIUMPH), University
of Wisconsin School of Medicine and Public Health
Background: First- and second-year medical students perceive that
they can make meaningful contributions to patient care and/or the
health care team’s learning. However, there is limited formal data
from more senior medical students regarding the value they add to
patient care and/or the team during their late-second through fourth
year-required clinical rotations.
Purpose: To obtain and codify senior medical students’ perceptions
regarding the value they add to patient care and/or the health care
team during their required clinical rotations.
Methods: Senior medical students at end of required clinical
rotations voluntarily completed an online, anonymous 5-item
“value added to clinical care” survey. Medical students checked if
they added value to 1 of 5 literature-derived categories and then
were asked to describe the situation in HIPAA-compliant format.
Analysis included frequency tabulations by value-added category
and qualitative analysis of narrative examples by category.
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Results: There were 131 respondents (53% women), 80% of whom
were within 12–24 months of graduation. In all, 67% of valuedadded contributions occurred in the outpatient setting, 23% in the
inpatient setting, and 10% in other settings (eg, 50/50 inpatient/
outpatient and emergency department). More than half of reports
(53%) focused on the category Patient’s/Family’s Experience of
Their Care (eg, enhancing patient’s understanding of their clinical
situation). For example, “I had a visit (with patient) who had a
gynecological concern but also had recently lost her twin sister.
I addressed her chief complaint but then spent some extra time
talking to her about how she is handling her loss and the grief she
is experiencing.” In other categories, 24% focused on added value
to Clinical Quality (eg, obtaining data/information from the patient
that impacted a clinical decision, identifying alternative approaches),
18% on Preceptor/Team Learning, and 3% of students reported
Patient Safety-related valued-added situations. (eg, shared a patient
safety concern/a potential risk).
Conclusion: Identifying the value added by students allows
educators to identify assets and potential opportunities (like patient
safety) to enhance student roles in clinical care. It also provides
rich data for educational leaders’ use with key clinical/community
stakeholders regarding how medical student education adds value to
patient care and the health care team.
Younger Hypertensive Patients Are More Likely to Have
Activated MyChart Accounts
Erin Harvey, Will Lehmann, Chella Bhagyam, Keyonna TaylorColeman, Catherine de Grandville, Deborah Simpson
Family Medicine, Aurora St. Luke’s Medical Center; Academic
Affairs, Advocate Aurora Health
Background: National epidemiological studies note that young
adults, those under 39 years old, tend to have less awareness of
their hypertension (HTN) diagnosis and are less likely than older
adults to have their blood pressure under control. Proposed barriers
to hypertension control in young adults include provider reluctance
to diagnose hypertension, hesitancy to prescribe antihypertensives,
less access to primary medical care, and patient perceptions of
their health status. HTN, as a silent disease, has major long-term
consequences on cardiovascular health. Identifying HTN patients by
age and seeking to control it is an important role for primary care.
Purpose: To determine if the percentage of patients with diagnosed
uncontrolled HTN who have signed up for MyAurora differs by age
(18–49 years, ≥50 years) and if patients on MyAurora were more
likely to have controlled their HTN.
Methods: Data were abstracted from electronic health records,
using the BI Launch Pad (the data warehouse for Aurora Quality
Improvement), for HTN by age, blood pressure control status, and
MyAurora account activation. Data were reviewed by each of two
family medicine residency clinic and then aggregated across the two
clinics using descriptive statistics.
Results: At one residency clinic, 29% (46 of 156) of 18–49-yearold adults had uncontrolled HTN; at the second clinic, 31% (43
of 139) of the same-aged patients had uncontrolled HTN. Rate of
adults ≥50 years old who had uncontrolled HTN was 18% (144 of
816) and 23% (85 of 364), by respective clinic. When comparing
account activation for MyAurora across our two clinics, we found
49% of patients 18–49 years old with diagnosed HTN had signed
up while only 27% of patients ≥50 years old with diagnosed HTN
had activated their accounts. Across our two clinics, across all ages,
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hypertensive patients who had signed up for MyAurora were 2.3%
more likely to have blood pressure control; however, in the younger
adult hypertensive population, patients signed up for MyAurora
were 8.1% more likely to have controlled blood pressure compared
to their unenrolled peers.
Conclusion: Consistent with the literature, the percentage of
patients with uncontrolled hypertension decreases with age in
our primary care clinics. Younger hypertensive patients (18–49
years of age) were more likely to sign up for MyAurora. Higher
MyAurora utilization rates for this age group points to its potential
use as an intervention for improving blood pressure control in these
hypertensive adults.
Quality Improvement Project to Increase Breast Cancer
Screening in an Internal Medicine Clinic
Michael Peliska, Dereje Siyum, Zeba Shethwala, Moaz
Hamed, Matt Boese, Hassan Homida, Hina Mahboob, Biana
Leybishkis
Internal Medicine, Aurora Sinai Medical Center; Aurora UW
Medical Group
Background: Breast cancer is the most common non-skin cancer
among American women, accounting for 7% of all cancer deaths
each year. Fortunately, when detected early with regular screening
mammograms, the 5-year survival rate for breast cancer approaches
99%. Resident clinics such as ours that serve an underserved urban
population bear the brunt of this challenge.
Purpose: To improve the completion percentage of screening
mammograms in our underserved urban community from 73% to
80%. We looked to see if primary care providers and clinic staff
could utilize the methods as described herein as effective ways to
improve breast cancer screening rates in our community.
Methods: We sought to achieve this goal by reviewing our
patient’s records to find individuals with a care gap specifically
regarding annual breast cancer screening. Once identified, we
would personally telephone eligible patients once per week to
discuss their breast cancer screening status, explain the risks and
benefits of screening mammograms, and encourage them to perform
appropriate testing. If they were agreeable, patients were provided a
phone number to call and schedule their mammogram. Additional
phone calls and mail reminders were sent to patients who agreed to
complete mammograms as a way to follow up and encourage timely
completion of the screening test.
Results: The initial 6-month data indicated a change in our breast
cancer screening completion percentage from 73% to 77%. Just
1 phone call per provider per week led to a 4% improvement in
our breast cancer screening completion rate. This outcome is
preliminary, and we are aiming for more significant improvement
in the following months.
Conclusion: Our findings indicate that identifying and contacting
patients who are overdue on their preventive health measures,
specifically screening mammograms, can have a measurable impact.
While the COVID-19 pandemic did affect our abilities to reach our
original goal, the results thus far are promising and suggest that with
continued effort our 80% goal is reachable.
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Measures to Enhance Breast Cancer Screening
Payal Sharma, Ifreah Usmaiel, Jalel Hunde, David Hamel
Internal Medicine, Aurora Sinai Medical Center; Aurora UW
Medical Group
Background: Breast cancer is responsible for the deaths of more
than 40,000 women in the United States. The U.S. Preventive
Services Task Force (USPSTF) recommends biannual mammograms
for all women 50–74 years of age. Today, the 5-year survival of
breast cancer is almost 90%, compared to 75% in 1975. Breast
cancer screening (BCS) leads to earlier detection and treatment,
reduced mortality, and reduced need for toxic treatments. Despite
the documented screening benefits, only 64%–81% of the population
meeting the criteria for regular BCS is regularly screened.
Purpose: The USPSTF guideline for BCS is a quality improvement
(QI) measure that is tracked for primary care physicians (PCPs)
in Advocate Aurora Health. PCPs in our clinic had a BCS rate of
67% for the eligible patients assigned to them in September 2019
(system goal: ≥84%). We hypothesized that regular BCS has been
limited by factors including inadequate emphasis, education, and
reminders. By April 1, 2020, our PCPs aim to fill these gaps and
improve patient outcomes by increasing our BCS rate by ≥10%.
Methods: The study population included our clinic PCPs (authors
P.S., I.U., J.H.) who performed personal outreach to their patients
due for BCS. Every month, data were generated through the
system’s QI process, which included percentage of eligible BCS
patients who were up-to-date and a list of patients who were due.
The process for the study was our routine clinic workflow, plus
dedicated outreach to our patients (ie, the intervention). We called,
mailed letters, or messaged through our electronic messaging system
(MyAdvocateAurora) to our patients who were due for BCS. We
advised our patients to complete a screening mammogram given
supporting facts. A screening mammogram was ordered for those
who agreed. We provided the patients with a phone number to
schedule it. For patients who had BCS in other systems, we collected
the results through the usual process and updated it in our system.
Results: At the start of our QI projects, only 67% of 50–75-year-old
patients had up-to-date BCS. By continuous and dedicated outreach,
our BCS score has improved to 75% by February 20, 2020.
Conclusion: To improve breast cancer screening rates and decrease
breast cancer-related mortality, we established individualized
outreach. These efforts increased QI measures. However, our project
was not able to continue until April 1, 2020, as planned due to
indefinite closure of nonessential clinic visits starting at the end of
February 2020, due to the COVID-19 pandemic. Even though we
were not able to continue the project, by continuing these dedicated
outreach reminders, we might have been able to reach our BCS rate
goal of ≥77% if it were not for the pandemic.
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